WO2010073248A3 - Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux - Google Patents
Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux Download PDFInfo
- Publication number
- WO2010073248A3 WO2010073248A3 PCT/IL2009/001212 IL2009001212W WO2010073248A3 WO 2010073248 A3 WO2010073248 A3 WO 2010073248A3 IL 2009001212 W IL2009001212 W IL 2009001212W WO 2010073248 A3 WO2010073248 A3 WO 2010073248A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- classification
- origin
- tissue
- gene expression
- tumor samples
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Databases & Information Systems (AREA)
- Artificial Intelligence (AREA)
- Data Mining & Analysis (AREA)
- Software Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- General Engineering & Computer Science (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Bioethics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Signal Processing (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200980157378XA CN102333888B (zh) | 2008-12-24 | 2009-12-23 | 用于肿瘤样本起源组织分类的基因表达签名 |
IL212979A IL212979A (en) | 2008-12-24 | 2011-05-18 | Gene expression signature to classify the source tissue of cancer tumor samples |
US13/167,489 US8802599B2 (en) | 2007-03-27 | 2011-06-23 | Gene expression signature for classification of tissue of origin of tumor samples |
US13/856,190 US9096906B2 (en) | 2007-03-27 | 2013-04-03 | Gene expression signature for classification of tissue of origin of tumor samples |
US14/320,113 US20140315739A1 (en) | 2007-03-27 | 2014-06-30 | Gene expression signature for classification of tissue of origin of tumor samples |
US14/746,487 US20150368724A1 (en) | 2007-03-27 | 2015-06-22 | Methods and materials for classification of tissue of origin of tumor samples |
US15/853,258 US20180127835A1 (en) | 2007-03-27 | 2017-12-22 | Gene expression signature for classification of tissue of origin of tumor samples |
US15/909,145 US20190032142A1 (en) | 2007-03-27 | 2018-03-01 | Methods and materials for classification of tissue of origin of tumor samples |
US16/226,406 US20190241966A1 (en) | 2007-03-27 | 2018-12-19 | Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14064208P | 2008-12-24 | 2008-12-24 | |
US61/140,642 | 2008-12-24 |
Related Parent Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/532,940 Continuation-In-Part US20100178653A1 (en) | 2007-03-27 | 2008-03-20 | Gene expression signature for classification of cancers |
PCT/IL2008/000396 Continuation-In-Part WO2008117278A2 (fr) | 2007-03-27 | 2008-03-20 | Signature d'une expression génique permettant la classification des cancers |
US53294009A Continuation-In-Part | 2007-03-27 | 2009-09-24 | |
PCT/IL2011/000849 Continuation-In-Part WO2012070037A2 (fr) | 2007-03-27 | 2011-11-01 | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/167,489 Continuation-In-Part US8802599B2 (en) | 2007-03-27 | 2011-06-23 | Gene expression signature for classification of tissue of origin of tumor samples |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010073248A2 WO2010073248A2 (fr) | 2010-07-01 |
WO2010073248A3 true WO2010073248A3 (fr) | 2010-09-16 |
Family
ID=42288202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2009/001212 WO2010073248A2 (fr) | 2007-03-27 | 2009-12-23 | Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102333888B (fr) |
WO (1) | WO2010073248A2 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9096906B2 (en) | 2007-03-27 | 2015-08-04 | Rosetta Genomics Ltd. | Gene expression signature for classification of tissue of origin of tumor samples |
WO2012070037A2 (fr) | 2010-11-22 | 2012-05-31 | Rosetta Genomics Ltd. | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux |
AU2009253675A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
JP6257125B2 (ja) | 2008-11-17 | 2018-01-10 | ベラサイト インコーポレイテッド | 疾患診断のための分子プロファイリングの方法および組成物 |
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
EP3360978A3 (fr) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Procédés pour le diagnostic d'affections thyroïdiennes |
US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
WO2011154008A1 (fr) * | 2010-06-11 | 2011-12-15 | Rigshospitalet | Classification de micro-arn de néoplasie folliculaire de la thyroïde |
WO2012010584A1 (fr) * | 2010-07-20 | 2012-01-26 | Febit Holding Gmbh | Ensembles de miarn complexes en tant que nouveaux biomarqueurs pour le cancer gastrique |
WO2012068400A2 (fr) | 2010-11-17 | 2012-05-24 | Asuragen, Inc. | Micro-arn utilisés comme biomarqueurs pour faire la distinction entre des néoplasmes thyroïdiens bénins et malins |
EP2505663A1 (fr) | 2011-03-30 | 2012-10-03 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Procédé pour identifier des individus asymptomatiques à haut risque touchés par un cancer du poumon à l'état précoce au moyen de la détection d'ARNmi dans les liquides corporels |
EP2691545B1 (fr) * | 2011-03-28 | 2017-06-14 | Rosetta Genomics Ltd | Procédés pour la classification des cancers du poumon |
US9568483B2 (en) * | 2011-04-18 | 2017-02-14 | Cornell University | Molecular subtyping, prognosis and treatment of prostate cancer |
JP6011945B2 (ja) * | 2011-05-20 | 2016-10-25 | 公一 中城 | マイクロrna又はその発現系を含む組成物 |
US8831327B2 (en) | 2011-08-30 | 2014-09-09 | General Electric Company | Systems and methods for tissue classification using attributes of a biomarker enhanced tissue network (BETN) |
ES2688619T3 (es) * | 2011-12-22 | 2018-11-05 | Interna Technologies B.V. | MiARN para tratar el cáncer de cabeza y de cuello |
EP2653558B1 (fr) | 2012-04-18 | 2015-10-07 | Roche Diagniostics GmbH | Procédé de détection de cibles d'acide nucléique à l'aide d'un classificateur statistique |
US11035005B2 (en) | 2012-08-16 | 2021-06-15 | Decipher Biosciences, Inc. | Cancer diagnostics using biomarkers |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
CN114606309A (zh) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | 使用机器学习和高维转录数据的诊断系统和方法 |
EP3504348B1 (fr) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Utilisation de signatures génomiques en vue d'une prédiction de la réactivité de patients atteints d'un cancer de la prostate à une radiothérapie postopératoire |
US11208697B2 (en) | 2017-01-20 | 2021-12-28 | Decipher Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
EP3593140A4 (fr) | 2017-03-09 | 2021-01-06 | Decipher Biosciences, Inc. | Sous-typage du cancer de la prostate pour prédire la réponse à une thérapie hormonale |
AU2018266733A1 (en) | 2017-05-12 | 2020-01-16 | Veracyte, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
CN110706749B (zh) * | 2019-09-10 | 2022-06-10 | 至本医疗科技(上海)有限公司 | 一种基于组织器官分化层次关系的癌症类型预测系统和方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050059005A1 (en) * | 2001-09-28 | 2005-03-17 | Thomas Tuschl | Microrna molecules |
US20060084056A1 (en) * | 2002-02-13 | 2006-04-20 | Nadia Harbeck | Methods for selecting treatment regimens and predicting outcomes in cancer patients |
US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
US20070083945A1 (en) * | 2000-03-10 | 2007-04-12 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
US20080076674A1 (en) * | 2006-07-06 | 2008-03-27 | Thomas Litman | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer |
US20080305962A1 (en) * | 2005-07-29 | 2008-12-11 | Ralph Markus Wirtz | Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies |
-
2009
- 2009-12-23 CN CN200980157378XA patent/CN102333888B/zh active Active
- 2009-12-23 WO PCT/IL2009/001212 patent/WO2010073248A2/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070083945A1 (en) * | 2000-03-10 | 2007-04-12 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
US20050059005A1 (en) * | 2001-09-28 | 2005-03-17 | Thomas Tuschl | Microrna molecules |
US20060084056A1 (en) * | 2002-02-13 | 2006-04-20 | Nadia Harbeck | Methods for selecting treatment regimens and predicting outcomes in cancer patients |
US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
US20080305962A1 (en) * | 2005-07-29 | 2008-12-11 | Ralph Markus Wirtz | Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies |
US20080076674A1 (en) * | 2006-07-06 | 2008-03-27 | Thomas Litman | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer |
Non-Patent Citations (1)
Title |
---|
SCHULTZ ET AL.: "MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorageindependent growth.", CELL RES., vol. 18, no. 5, May 2008 (2008-05-01), pages 549 - 57 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010073248A2 (fr) | 2010-07-01 |
CN102333888A (zh) | 2012-01-25 |
CN102333888B (zh) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010073248A3 (fr) | Signature d'expression génétique pour la classification de tissu provenant d'échantillons tumoraux | |
WO2008117278A3 (fr) | Signature d'une expression génique permettant la classification des cancers | |
WO2012070037A3 (fr) | Procédés et matériaux pour la classification de tissus originaires d'échantillons tumoraux | |
AR061136A1 (es) | Procedimiento | |
EP3106168A3 (fr) | Ciblage des microarn mir-409-5p, mir-379 et mir-154* pour traiter la métastase osseuse du cancer de la prostate et le cancer du poumon résistant aux médicaments | |
WO2010045318A3 (fr) | Cibles géniques et protéiques exprimées par des gènes représentant des profils de biomarqueurs et des jeux de signatures par type de tumeurs | |
EP2198021A4 (fr) | Ebi3, dlx5, nptx1 et cdkn3 pour des gènes cibles de thérapie et de diagnostic de cancer de poumon | |
WO2009153775A3 (fr) | Procédés permettant de différencier différents types de cancers du poumon | |
AU2003216311A8 (en) | Rna interference mediated inhibition of grb2-associated binding protein 2 (gab2) gene expression using short interfering nucleic acid (sina) | |
WO2010026488A3 (fr) | Procédés et kits de séquençage d'acides nucléiques | |
WO2013158309A3 (fr) | Ciblage génique non disruptif | |
WO2010022166A3 (fr) | Micro-arn (arnmi) et neurofibromatose de type 1 : un rôle en diagnostic et thérapie | |
WO2003070884A3 (fr) | Inhibition de l'expression du gene de la mdr p-glycoproteine induite par l'interference d'arn, au moyen d'acide nucleique interferant court (sina) | |
WO2008079269A3 (fr) | Nouveaux procédés pour une analyse fonctionnelle de données expérimentales à haut débit et groupes de gènes identifiés à partir de ceux-ci | |
WO2011057034A3 (fr) | Catenae : cellules souches cancéreuses des séreuses | |
EP2647711A3 (fr) | Voies d'export alternatives pour l'interférence d'ARN exprimée par vecteur | |
WO2011094335A3 (fr) | Signatures de microarn prédictives de la réponse à une thérapie anti-her2 | |
WO2008086182A3 (fr) | Utilisation de signatures de gène pour concevoir de nouveaux régimes de traitement de cancer | |
WO2014057357A3 (fr) | Méthode pour le diagnostic, le pronostic et le traitement d'une métastase du cancer de la prostate | |
Podergajs et al. | Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF | |
AU2015308620A8 (en) | Early lung cancer detection by DNA methylation phenotyping of sputum-derived cells | |
EA201301336A1 (ru) | Лечение рака комбинацией молекул днк, имитирующих двухнитевые разрывы, и гипертермии | |
WO2009066291A3 (fr) | Signature d'expression de micro-arn pour la détermination de l'origine de tumeurs | |
WO2010003420A3 (fr) | Traitement du psoriasis et de maladies apparentées par modulation de miarn | |
WO2003070887A3 (fr) | Inhibition mediee par interference d'arn de l'expression du gene de la proteine ezh2 du groupe polycomb a l'aide d'un acide nucleique court interferent (sina) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980157378.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09834226 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 212979 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09834226 Country of ref document: EP Kind code of ref document: A2 |